Expression of a B‐cell marker, CD24, on nasopharyngeal carcinoma cells

作者: Lorainc Karran , Michael Jones , Gary Morley , Susan Van Noorden , Paul Smith

DOI: 10.1002/IJC.2910600422

关键词:

摘要: Random sequencing of clones from a lambda gt10 cDNA library, made mRNA expressed in an Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) has revealed the gene transcript human CD24. The CD24 antigen, glycosylphosphatidylinositol-anchored cell surface molecule, been identified as B-cell marker that is lost during maturation. We show here it on 3 NPC xenografts, previously defined consisting poorly differentiated epithelial cells, and biopsy. In case former, level expression corresponds to EBV load. A B-lymphoblastoid line carrying same genome one tumours, C15, EBV-negative Burkitt's lymphoma do not display but epithelial-like cells laryngeal tumour (Hep2) express it. Our data suggest may be differentiation only for B also have indirect association with expression.

参考文章(22)
M.M. Hitt, M.J. Allday, T. Hara, L. Karran, M.D. Jones, P. Busson, T. Tursz, I. Ernberg, B.E. Griffin, EBV gene expression in an NPC-related tumour. The EMBO Journal. ,vol. 8, pp. 2639- 2651 ,(1989) , 10.1002/J.1460-2075.1989.TB08404.X
E. S. Jaffe, S. M. Hsu, Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues. American Journal of Pathology. ,vol. 114, pp. 387- 395 ,(1984)
M Cordier, A Calender, M Billaud, U Zimber, G Rousselet, O Pavlish, J Banchereau, T Tursz, G Bornkamm, G M Lenoir, Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Journal of Virology. ,vol. 64, pp. 1002- 1013 ,(1990) , 10.1128/JVI.64.3.1002-1013.1990
F Wang, C Gregory, C Sample, M Rowe, D Liebowitz, R Murray, A Rickinson, E Kieff, Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Journal of Virology. ,vol. 64, pp. 2309- 2318 ,(1990) , 10.1128/JVI.64.5.2309-2318.1990
P Busson, R McCoy, R Sadler, K Gilligan, T Tursz, N Raab-Traub, Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. Journal of Virology. ,vol. 66, pp. 3257- 3262 ,(1992) , 10.1128/JVI.66.5.3257-3262.1992
P R Smith, Y Gao, L Karran, M D Jones, D Snudden, B E Griffin, Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. Journal of Virology. ,vol. 67, pp. 3217- 3225 ,(1993) , 10.1128/JVI.67.6.3217-3225.1993
R Bataille, C Boucheix, C Duperray, J Brochier, B Klein, J F Cantaloube, J M Boiron, D Maraninchi, M Attal, T Lavabre-Bertrand, The CD24 antigen discriminates between pre-B and B cells in human bone marrow. Journal of Immunology. ,vol. 145, pp. 3678- 3683 ,(1990)
Robin Fåhraeus, Hu Li Fu, Ingemar Ernberg, Jurgen Finke, Martin Rowe, George Klein, Kerstin Falk, Ethel Nilsson, Manmohan Yadav, Pierre Busson, Thomas Tursz, Bengt Kallin, Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer. ,vol. 42, pp. 329- 338 ,(1988) , 10.1002/IJC.2910420305
Uwe Zangemeister-Wittke, Hans-Peter Lehmann, Robert Waibel, Edward J. Wawrzynczak, Rolf A. Stahel, Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft. International Journal of Cancer. ,vol. 53, pp. 521- 528 ,(1993) , 10.1002/IJC.2910530327